Drug Interactions between rifabutin and rifampin
This report displays the potential drug interactions for the following 2 drugs:
- rifabutin
- rifampin
Interactions between your drugs
No interactions were found between rifabutin and rifampin. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
rifabutin
A total of 350 drugs are known to interact with rifabutin.
- Rifabutin is in the drug class rifamycin derivatives.
- Rifabutin is used to treat the following conditions:
rifampin
A total of 495 drugs are known to interact with rifampin.
- Rifampin is in the drug class rifamycin derivatives.
-
Rifampin is used to treat the following conditions:
- Bartonellosis
- Endocarditis
- Haemophilus influenzae Prophylaxis
- Legionella Pneumonia
- Leprosy
- Leprosy, Borderline
- Leprosy, Tuberculoid
- Meningitis
- Meningococcal Meningitis Prophylaxis
- Mycobacterium avium-intracellulare, Treatment
- Nasal Carriage of Staphylococcus aureus
- Tuberculosis, Active
- Tuberculosis, Latent
- Tuberculosis, Prophylaxis
Drug and food interactions
No interactions were found. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Rifamycin derivatives
Therapeutic duplication
The recommended maximum number of medicines in the 'rifamycin derivatives' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'rifamycin derivatives' category:
- rifabutin
- rifampin
Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.
See Also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
